Physician profile
Mariselis Rosa Sanchez
NPI 1205142171
$6,092.35
in general payments reported to CMS, 2019-2025
16 companies · $5,215 in 2025
The $5,215 reported for 2025 was more than what 87% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $163 · 2022: $18.32 · 2023: $130 · 2024: $428 · 2025: $5,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,548 · Travel and Lodging: $1,181 · Food and Beverage: $1,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,547.50 |
| Travel and Lodging | $1,181.49 |
| Food and Beverage | $1,043.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $5,239.19 | 2023-2025 | |
| Mallinckrodt Hospital Products INC. | $222.70 | 2020-2024 | Acthar |
| Glaxosmithkline, LLC. | $124.99 | 2025 | Benlysta |
| Kyowa Kirin, INC. | $110.44 | 2023-2024 | Crysvita |
| Mallinckrodt Enterprises LLC | $105.12 | 2019 | |
| Alnylam Pharmaceuticals INC. | $54.78 | 2024-2025 | Oxlumo, Givlaari |
| Novartis Pharmaceuticals Corporation | $37.28 | 2019-2020 | |
| Mozarc Medical US LLC | $33.08 | 2025 | Carpediem |
| Azurity Pharmaceuticals, INC. | $29.52 | 2025 | Katerzia |
| Calliditas Therapeutics US INC. | $27.16 | 2025 | Tarpeyo |
| Alexion Pharmaceuticals, INC. | $20.27 | 2020 | |
| Baxter Healthcare | $19.66 | 2019 | |
| Ani Pharmaceuticals, INC. | $18.50 | 2024 | Valsartan |
| Travere Therapeutics, INC. | $18.32 | 2022 | |
| Hologic Sales and Service, LLC | $17.91 | 2023 | Coolseal Generator |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.43 | 2023 | Inpen Smart Insulin Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariselis Rosa Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.